Transdigm Q1 2020 Earnings Report
Key Takeaways
TransDigm Group reported a strong first quarter with net sales increasing by 47.5% to $1,465 million and net income from continuing operations rising by 18.9% to $233 million. The organic sales growth was 8.7%, with the Esterline acquisition contributing significantly to the overall increase. The company reaffirmed its fiscal year 2020 guidance for sales, EBITDA As Defined, and adjusted earnings per share.
Net sales increased by 47.5% to $1,465 million, driven by organic growth and the Esterline acquisition.
Net income from continuing operations grew by 18.9% to $233 million.
Adjusted earnings per share rose by 28.1% to $4.93.
EBITDA As Defined increased by 39.8% to $681 million, representing 46.5% of net sales.
Transdigm
Transdigm
Forward Guidance
TransDigm is maintaining its fiscal 2020 sales, EBITDA As Defined and adjusted earnings per share guidance.